Renaissance Technologies LLC acquired a new stake in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 66,000 shares of the company’s stock, valued at approximately $457,000. Renaissance Technologies LLC owned 0.16% of Adlai Nortye as of its most recent filing with the SEC.
Separately, SmartHarvest Portfolios LLC grew its holdings in shares of Adlai Nortye by 8.5% during the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock valued at $113,000 after acquiring an additional 1,279 shares in the last quarter. 35.21% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages recently issued reports on ANL. Oppenheimer assumed coverage on Adlai Nortye in a report on Thursday, May 28th. They set an “outperform” rating and a $32.00 price objective for the company. Cantor Fitzgerald began coverage on Adlai Nortye in a research note on Monday, June 22nd. They set an “overweight” rating for the company. HC Wainwright lifted their price target on Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a report on Monday, April 20th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Finally, JonesTrading initiated coverage on Adlai Nortye in a research note on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target for the company. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $24.25.
Adlai Nortye Stock Up 0.7%
ANL stock opened at $13.34 on Tuesday. Adlai Nortye Ltd. Sponsored ADR has a 1 year low of $0.88 and a 1 year high of $17.25. The company has a fifty day simple moving average of $11.50 and a 200 day simple moving average of $10.88.
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Read More
- Five stocks we like better than Adlai Nortye
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding ANL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Free Report).
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
